Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 646 of 6351
-
Can a smarter heart map make risky ablation safer and more effective?
Disease control Recruiting nowThis is a multicenter, prospective, parallel, randomized controlled trial to test for non-inferiority with an ILAM-guided VT ablation compared to conventional voltage- based ablation. The study has two treatment arms: conventional voltage mapping and ablation (control arm). In th…
Sponsor: University of Arizona • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Blood platelet RNA test could revolutionize ovarian cancer detection
Diagnosis Recruiting nowThe purpose of the SENTRY (Stability Enhanced Transcriptional Analytics) Study is to test whether combining a unique analytical approach with changes in platelet RNA expression accurately diagnoses ovarian cancer. Using retrospective data, the investigators have developed an appr…
Sponsor: University of Utah • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New combo therapy aims to tame thyroid eye disease
Disease control Recruiting nowThyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO…
Phase 4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Could a common drug stop a rare liver disease from returning after transplant?
Prevention Recruiting nowThis study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurrence of primary sclerosing cholangitis after liver transplantation, compared with a historical control cohort that was not treated with
Phase 2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Jul 19, 2026 00:00 UTC
-
A gentle buzz on the ear: could nerve stimulation soothe the toll of breast cancer?
Symptom relief CompletedThis study tests whether a gentle, non-invasive device called mindvybe can help improve feelings of wellbeing in people who have had breast cancer. Mindvybe delivers mild electrical stimulation near the vagus nerve (on the ears and neck) and to specific points on the earlobes. A…
Sponsor: The Healing Consciousness Foundation • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
New depression pill shows promise in Late-Stage trial
Symptom relief OngoingA Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - Emerge
Phase 3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Can a higher radiation dose help older brain cancer patients live longer?
Disease control Recruiting nowGlioblastoma (GBM) is an aggressive malignancy of the central nervous system. Older adults with GBM have a unique constellation of medical, psychosocial, and supportive care needs. To address these challenges, prior work has evaluated the feasibility of hypofractionation, a treat…
Phase 2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 26, 2026 17:50 UTC
-
Weight-Loss drug semaglutide takes on atrial fibrillation in new trial
Disease control Recruiting nowThe goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard A…
Phase 3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could carbon dioxide replace contrast dye to save kidneys?
Disease control Recruiting nowThe primary objective of the trial is to evaluate if an iodinated contrast medium sparing strategy using automated Carbon Dioxide (CO2) Injection prevents Major Adverse Kidney Events up to 90 days (MAKE90) in patients at moderately elevated risk for contrast-associated acute kidn…
Phase 3 • Sponsor: University of Leipzig • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a simple supplement revive sperm health and testosterone?
Disease control CompletedThis study will evaluate the effects of the WeNatal For Him supplement on markers of male fertility over a 3-month period. The trial is a single-arm, unblinded study enrolling 40 male participants who will take 3 capsules of the test product daily in the morning with their first …
Sponsor: WeNatal • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a new heart ablation technique work without x-rays?
Disease control CompletedObjective: To evaluate the feasibility, acute, and three-month efficacy and safety of near-zero fluoroscopy PVI performed with the Farapulse system (Faravawe catheter, Faradrive sheath, Faraview module). Primary hypothesis: High durability of PVI is achievable with minimal fluor…
Sponsor: Semmelweis University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Could a smartphone alert replace daily blood thinners for AF?
Disease control OngoingAtrial Fibrillation (AF) is the most common sustained cardiac arrhythmia, affecting 1-2 million people in the UK. AF is characterised by uncoordinated electrical activation and ineffective contraction of the upper cardiac chambers. AF can occur in temporary episodes, as in paroxy…
Sponsor: Oxford University Hospitals NHS Trust • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can insulin eye drops quench dry eyes?
Disease control CompletedThis is a parallel randomized controlled trial for the treatment of dry eye disease. The main objective is to investigate the efficacy and safety of the use of insulin eye drops in the control of moderate-severe dry eye disease. Topical insulin drops will be compared to artificia…
Phase 4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Weekly HIV pill could replace daily doses
Disease control OngoingInvestigators are trying to find better treatments for people with HIV-1. In this clinical study, investigators want to see how well a new treatment called ISL+ULO, taken once a week, works compared to an existing treatment called BIC/FTC/TAF, which is taken every day. Investigat…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Arm cuff may boost brain recovery after stroke: major trial underway
Disease control Recruiting nowA substantial body of basic and clinical research has demonstrated the protective effects of remote ischemic conditioning (RIC) in ischemic stroke. While these clinical studies support the safety of RIC, the neuroprotective benefits of RIC in acute ischemic stroke (AIS) patients …
Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Dissolvable stent could save legs from amputation
Disease control Recruiting nowThe objective of this prospective, single-blinded, randomized controlled trial is to evaluate the safety and efficacy of the MAGNITUDE BRS System for the planned treatment of narrowed infrapopliteal lesions. Approximately 276 subjects will be randomized in a 1:1 ratio. The clinic…
Sponsor: R3 Vascular Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New hope for bladder cancer: trial pits top drugs against each other
Disease control Recruiting nowThe purpose of this study is to compare the effectiveness of different FDA-approved/NCCN-recommended drug treatments for NMIBC. In particular, the FDA-approved drug nadofaragene firadenovec will be compared to usual care with other NCCN-recommended standard treatments for NMIBC (…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug cocktail aims to fight tough gynecological cancers
Disease control Recruiting nowThis is a Phase 2, open-label, global, multi-arm study to evaluate efficacy and safety of relacorilant in combination with other treatments in patients with gynecological cancers.
Phase 2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New imaging agent aims to unmask hidden prostate cancer recurrences
Diagnosis Recruiting nowThis phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emission tomography \[PET\]/computed tomography \[CT\]) for detecting prostate cancer in patients who have increasing prostate-specific antigen levels following prior treatment (biochemical recurrence) but wh…
Early phase 1 • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New hope for blood cancer: targeted therapy combo shows promise in phase 2 trial
Disease control Recruiting nowResearchers are looking for ways to treat germinal center B-cell-like diffuse large B-cell lymphoma (GCB DLBCL). DLBCL is a fast-growing blood cancer that affects B-cells. GCB is a type of DLBCL that affects young B-cells that are still maturing. The goal of this study is to lea…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC